Hepatitis

In 2026, the relationship between FECO (Full Extract Cannabis Oil) and Hepatitis is a significant focus of hepatology research. While FECO is not a cure for the viral infection itself, its "whole-plant" compounds are being studied for their ability to protect liver tissue and manage the debilitating symptoms of both viral and autoimmune hepatitis.

1. Antiviral Potential (Hepatitis C)

Recent laboratory studies (2025) have spotlighted specific cannabinoids within FECO for their direct impact on the Hepatitis C virus (HCV).

Viral Replication: CBD, a major component of FECO, has demonstrated the ability to inhibit HCV replication by up to 86% in in vitro (cell culture) models. It appears to interfere with the virus's ability to hijack liver cells.

Treatment Adherence: Historically, hepatitis treatments (like Interferon) had severe side effects. FECO is frequently used by patients to manage the nausea, fatigue, and depression caused by these antiviral drugs, helping them complete their full course of treatment.

2. Anti-Inflammatory & Anti-Fibrotic Effects

Hepatitis causes chronic inflammation that leads to fibrosis (scarring) and eventually cirrhosis. FECO targets this through the Endocannabinoid System (ECS):

CB2 Receptor Activation: The liver’s CB2 receptors are "upregulated" during injury. FECO activates these receptors to suppress pro-inflammatory cytokines and reduce the recruitment of immune cells that attack liver tissue.

Apoptosis of Stellate Cells: FECO may help induce "programmed cell death" in activated hepatic stellate cells—the primary cells responsible for producing scar tissue in the liver—potentially slowing the progression of fibrosis.

3. Protection Against "Secondary" Liver Stress

Many patients with viral hepatitis also face metabolic or alcohol-related liver stress.

Oxidative Stress Reduction: FECO is rich in antioxidants and terpenes (like Limonene) that help the liver process toxins and reduce "steatosis" (fat buildup), which is a common complication in Hepatitis C.

Autoimmune Support: For those with Autoimmune Hepatitis, FECO’s immunosuppressive qualities help "calm" the T-cells and macrophages that mistakenly attack the liver.

Usage for Hepatitis

In 2026, clinical guidelines for liver patients emphasize:

CBD-Dominant Ratios: To avoid the potentially pro-fibrotic effects of high THC, patients often use FECO with a high CBD:THC ratio (e.g., 20:1).

Oral Ingestion: Avoiding smoking is critical to prevent additional oxidative stress on the body.

Monitoring: Regular liver function tests (LFTs) are essential when starting a FECO regimen to ensure the liver is processing the oil safely.